Showing results (321-330 of 5,925) with videos related to

Sort By:
Pageof 593
The Prostate|September 30, 2015
Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancerJoshua M Corbin, Ryan F Overcash, Jonathan D Wren, et al.
The Prostate|December 29, 2015
NF-κB and androgen receptor variant expression correlate with human BPH progressionDavid C Austin, Douglas W Strand, Harold L Love, et al.
The Prostate|November 21, 2015
Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancerVincent A DiPippo, Holly M Nguyen, Lisha G Brown, et al.
The Prostate|January 19, 2016
Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancerJost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
The Prostate|January 1, 1989
Differential reaction of secretory and non-secretory proteins in hormone-treated Dunning tumorG Aumüller, B Hartley-Asp, J Seitz
The Prostate|September 2, 2014
ERG and CHD1 heterogeneity in prostate cancer: use of confocal microscopy in assessment of microscopic fociIrina V Tereshchenko, Hua Zhong, Marina A Chekmareva, et al.
The Prostate|October 21, 2015
Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapyMatthew J Pagano, Michael J Whalen, David J Paulucci, et al.
The Prostate|January 1, 1989
Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical studyS H Flüchter, H J Nelde, P Björk, et al.
The Prostate|November 11, 2015
Germline copy number variation analysis in Finnish families with hereditary prostate cancerVirpi H Laitinen, Oyediran Akinrinade, Tommi Rantapero, et al.
The Prostate|March 19, 2016
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerMartine P Roudier, Brian R Winters, Ilsa Coleman, et al.
Pageof 593